PATH, Seattle, Washington, USA;, Burnet Institute, Melbourne, Victoria, Australia.
PATH, Seattle, Washington, USA.
Int J Tuberc Lung Dis. 2018 Apr 1;22(4):425-428. doi: 10.5588/ijtld.17.0312.
New diagnostic tools for tuberculosis (TB) are urgently needed. To guide investment decisions, sufficient information regarding which test attributes are the most important for users and decision makers interested in introducing TB diagnostics should be made available.
To rank test attributes in a target product profile (TPP) in order of importance for a sputum smear replacement test for TB.
An online survey was administered among 33 participants representing 14 of the 22 TB high-burden countries. Respondents included laboratory personnel, national TB program managers, donors, technical experts, patients and researchers. Participants were asked to rank 21 TPP test attributes in order of importance using a maximum-differential method that required ranking of relative trade-offs.
Sensitivity was ranked as the most important test attribute, followed by maintenance/calibration, reagent kit storage/stability, sample preparation steps and time to results.
Consulting widely regarding which TPP attributes are valued most by users and decision-makers involved in introducing TB diagnostics can assist TB test developers to prioritize their investments, and guide decision making if trade-offs are necessary.
结核病(TB)的新诊断工具急需开发。为了指导投资决策,应该为有兴趣引入结核病诊断的用户和决策者提供有关哪些测试属性最重要的充分信息。
按照重要性顺序对目标产品特征(TPP)中的测试属性进行排序,以替代痰涂片检测结核病的检测方法。
对代表 22 个结核病高负担国家中的 14 个国家的 33 名参与者进行了在线调查。受访者包括实验室人员、国家结核病规划管理人员、捐助者、技术专家、患者和研究人员。参与者被要求使用需要对相对权衡进行排序的最大差异法,按照重要性对 21 个 TPP 测试属性进行排序。
灵敏度被列为最重要的测试属性,其次是维护/校准、试剂试剂盒储存/稳定性、样品制备步骤和结果获得时间。
咨询广泛的结核病诊断引入方面的用户和决策者,了解他们最看重哪些 TPP 属性,可以帮助结核病检测开发人员优先考虑投资,并在需要权衡取舍时指导决策。